Daniel Reinhorn
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 15, 2025
Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.Ori Aslan, Johnathan Arnon, Itamar Averbuch
|Apr 02, 2025
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies.Daniel Reinhorn, Mor Moskovitz, William D Tap
|Nov 28, 2024
Vascular endothelial growth factor and programmed cell death-1 inhibition in bone sarcomas.Daniel Reinhorn, Sandra P D'Angelo
|Mar 27, 2021
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.Daniel Reinhorn, Iryna Kuchuk, Tzippy Shochat
|Mar 20, 2020
Treatment beyond progression with immune checkpoint inhibitors in non-small-cell lung cancer.Daniel Reinhorn, Oded Jacobi, Oded Icht
Pageof 1
